[
    [
        {
            "time": "",
            "original_text": "龙头股突然躺倒？高瓴抛售躲过大跌，公募明星基金分歧显现",
            "features": {
                "keywords": [
                    "龙头股",
                    "高瓴",
                    "抛售",
                    "大跌",
                    "公募基金",
                    "分歧"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "龙头股突然躺倒？高瓴抛售躲过大跌，公募明星基金分歧显现",
                "Correlation": 6,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "【权益变动】凯莱英(6821.HK)获FMR LLC增持6.96万股",
            "features": {
                "keywords": [
                    "凯莱英",
                    "FMR LLC",
                    "增持"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【权益变动】凯莱英(6821.HK)获FMR LLC增持6.96万股",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "凯莱英（6821.HK/002821.SZ）：项目储备强大，新业务打开想象空间",
            "features": {
                "keywords": [
                    "凯莱英",
                    "项目储备",
                    "新业务",
                    "想象空间"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "凯莱英（6821.HK/002821.SZ）：项目储备强大，新业务打开想象空间",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "12月以来，大批医药企业正密集上市！",
            "features": {
                "keywords": [
                    "医药企业",
                    "密集上市"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "12月以来，大批医药企业正密集上市！",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "药明康德跌停 “要命”，“医药女神”葛兰旗下基金单日大跌4.24%",
            "features": {
                "keywords": [
                    "药明康德",
                    "跌停",
                    "葛兰",
                    "基金",
                    "大跌"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "药明康德跌停 “要命”，“医药女神”葛兰旗下基金单日大跌4.24%",
                "Correlation": 7,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 9,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 10,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【AH互动】凯莱英(06821)H股反弹超11% 料下半年新增产能1390立方米",
            "features": {
                "keywords": [
                    "凯莱英",
                    "H股",
                    "反弹",
                    "新增产能"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【AH互动】凯莱英(06821)H股反弹超11% 料下半年新增产能1390立方米",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "【异动股】凯莱英(06821.HK)涨10.42%",
            "features": {
                "keywords": [
                    "凯莱英",
                    "涨"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【异动股】凯莱英(06821.HK)涨10.42%",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 7,
                "Duration": 3,
                "Entity_Density": 9,
                "Market_Scope": 2,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "安信国际 | 医药行业：国内疫情有所反复，国产中和抗体联合疗法获批",
            "features": {
                "keywords": [
                    "医药行业",
                    "疫情",
                    "反复",
                    "中和抗体",
                    "疗法",
                    "获批"
                ],
                "sentiment_score": 0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "安信国际 | 医药行业：国内疫情有所反复，国产中和抗体联合疗法获批",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        }
    ]
]